Jeffrey David Weiner Reports 2.61% Stake in Psyence Biomedical Ltd. (PBM) via Schedule 13G/A

Jeffrey David Weiner filed a Schedule 13G/A on June 10, 2026, disclosing an ownership position in Psyence Biomedical Ltd. (PBM). According to the filing, Weiner beneficially owns 59,750 common shares, representing 2.61% of the company based on 2,293,307 total outstanding shares. This filing serves as an amendment to a previous report. The event triggering this filing occurred on February 25, 2026. The reporting person has sole voting and dispositive power over all 59,750 shares. Notably, the filing indicates that the reporting person now owns less than 5% of the class of securities, as reflected by the 'item5' certification. Weiner, a U.S. citizen based in Seattle, WA, certified that the shares were not acquired for the purpose of changing or influencing the control of the issuer. This position represents an increase from a previous 0% ownership level reported in the provided metadata, though the current total remains below the typical 5% threshold for active monitoring.